LABORATORIO FARMAC.ERFO (RK7) — Cash Flow Quality Index
LABORATORIO FARMAC.ERFO (RK7) has a Cash Flow Quality Index of 2.20x as of December 2023. Operating cash flow of €1.30 Million exceeds net income of €590.33K, indicating high earnings quality where cash backs reported profits. Explore RK7 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
LABORATORIO FARMAC.ERFO Cash Flow Quality Index (2021–2023)
Historical Cash Flow Quality Index for LABORATORIO FARMAC.ERFO across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RK7 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year earnings quality comparison for LABORATORIO FARMAC.ERFO. For live market cap and the full company financial profile, see LABORATORIO FARMAC.ERFO (RK7) total market value.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.20x | €1.30 Million | €590.33K | ▲ +106.5% |
| 2022 | 1.06x | €761.80K | €716.07K | ▼ -45.8% |
| 2021 | 1.96x | €2.27 Million | €1.16 Million | — |